Cardiac Safety of Fingolimod 0.5 mg during the First Dose Observation in 4-Month, Open-Label, Multi-Center FIRST Study in Patients with Relapsing MS

Cardiac Safety of Fingolimod 0.5 mg during the First Dose Observation in 4-Month, Open-Label, Multi-Center FIRST Study in Patients with Relapsing MS

Detalles Bibliográficos
Autores principales: Comi, G, Kappos, L, Palace, J, Gottschalk, R, Bijarnia, M, Keil, A, Tomic, D, von Rosenstiel, P, Gold, R
Formato: Conference item
Publicado: 2012

Ejemplares similares